Rodman & Renshaw Initiates Coverage on Passage Bio (NASDAQ:PASG)
Equities researchers at Rodman & Renshaw began coverage on shares of Passage Bio (NASDAQ:PASG – Get Free Report) in a research note issued on Tuesday, StockNewsAPI reports. The firm set a “buy” rating and a $7.00 price target on the stock. Separately, Canaccord Genuity Group lowered their price target on shares of Passage Bio from […]
More Stories
Analysts Set Carter’s, Inc. (NYSE:CRI) PT at $71.17
Shares of Carter’s, Inc. (NYSE:CRI – Get Free Report) have received an average rating of “Reduce” from the seven research...
Brokerages Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $7.00
Shares of Precigen, Inc. (NASDAQ:PGEN – Get Free Report) have been given an average rating of “Moderate Buy” by the...
StockNews.com Downgrades Advanced Energy Industries (NASDAQ:AEIS) to Sell
Advanced Energy Industries (NASDAQ:AEIS – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a...
TD Securities Boosts Sangoma Technologies (CVE:STC) Price Target to C$10.00
Sangoma Technologies (CVE:STC – Free Report) had its price objective boosted by TD Securities from C$8.00 to C$10.00 in a...
Judges Scientific’s (JDG) Buy Rating Reaffirmed at Berenberg Bank
Berenberg Bank reiterated their buy rating on shares of Judges Scientific (LON:JDG – Free Report) in a report published on...
AAON (NASDAQ:AAON) Rating Increased to Hold at StockNews.com
AAON (NASDAQ:AAON – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating...